EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection

Emma Brown, Gemma Swinscoe, Daniella A Lefteri iD, Ravi Singh iD, Amy Moran, Rebecca F Thompson, Daniel Maskell, Hannah Beaumont, Matthew J Bentham, Claire Donald iD, Alain Kohl, Andrew Macdonald und 5 weitere

eLife · 23.08.2024 · 13

DOI: 10.7554/elife.68404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 23.08.2024. Verfasst von Emma Brown und 16 weiteren Autor:innen. Beteiligte Einrichtung: Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Zika Virus, Antiviral Agents, Zika Virus Infection. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Leeds, UK Research and Innovation, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Flaviviruses , including Zika virus (ZIKV), are a significant global health concern, yet no licensed antivirals exist to treat disease. The small membrane (M) protein plays well-defined roles during viral egress and remains within virion membranes following release and maturation. However, it is unclear whether M plays a functional role in this setting. Here, we show that M forms oligomeric membrane-permeabilising channels in vitro, with increased activity at acidic pH and sensitivity to the prototypic channel-blocker, rimantadine. Accordingly, rimantadine blocked an early stage of ZIKV cell culture infection. Structure-based channel models, comprising hexameric arrangements of two trans -membrane domain protomers were shown to comprise more stable assemblages than other oligomers using molecular dynamics simulations. Models contained a predicted lumenal rimantadine-binding site, as well as a second druggable target region on the membrane-exposed periphery. In silico screening enriched for repurposed drugs/compounds predicted to bind to either one site or the other. Hits displayed superior potency in vitro and in cell culture compared with rimantadine, with efficacy demonstrably linked to virion-resident channels. Finally, rimantadine effectively blocked ZIKV viraemia in preclinical models, supporting that M constitutes a physiologically relevant target. This could be explored by repurposing rimantadine, or development of new M-targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zika VirusAntiviral AgentsZika Virus InfectionHumansAnimalsRimantadineChlorocebus aethiopsMolecular Dynamics SimulationViral Matrix ProteinsVero CellsViroporin Proteins

Stichwörter der Autor:innen

FlavivirusZikainfectious diseaseion channelmicrobiologymouserimantadineviroporinvirus entryviruses

Substanzen

Antiviral AgentsRimantadineViral Matrix ProteinsViroporin Proteins

Autor:innen und Institutionen

  • Astbury Centre for Structural and Molecular Biology, University of Leeds, Leeds, United Kingdom.
  • Leeds Institute of Medical Research, School of Medicine, Faculty of Medicine and Health, University of Leeds, St James' University Hospital, Leeds, United Kingdom.
  • School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
  • School of Chemistry, Faculty of Maths and Physical Sciences, University of Leeds, Leeds, United Kingdom.
  • MRC and University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom.
  • Leeds Institute for Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, United Kingdom.

ORCID-Profile: Daniella A Lefteri, Ravi Singh, Claire Donald, Antreas C Kalli, Stephen Griffin

Förderung

  • University of Leeds
  • UK Research and Innovation
  • Medical Research Council

Zitieren

APA

Brown, E., Swinscoe, G., Lefteri, D. A., Singh, R., Moran, A., Thompson, R. F., Maskell, D., Beaumont, H., Bentham, M. J., Donald, C., Kohl, A., Macdonald, A., Ranson, N., Foster, R., McKimmie, C. S., Kalli, A. C., & Griffin, S. (2024). Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection. eLife, 13. https://doi.org/10.7554/elife.68404

Vancouver

Brown E, Swinscoe G, Lefteri DA, Singh R, Moran A, Thompson RF, et al. Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection. eLife. 2024;13. doi:10.7554/elife.68404

BibTeX
@article{Brown2024,
  author = {Brown, Emma and Swinscoe, Gemma and Lefteri, Daniella A and Singh, Ravi and Moran, Amy and Thompson, Rebecca F and Maskell, Daniel and Beaumont, Hannah and Bentham, Matthew J and Donald, Claire and Kohl, Alain and Macdonald, Andrew and Ranson, Neil and Foster, Richard and McKimmie, Clive S and Kalli, Antreas C and Griffin, Stephen},
  title = {Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.68404}
}
Kostenlos starten →